Global Meningococcal Vaccine Market Growth 2025-2031

Global Meningococcal Vaccine Market Growth 2025-2031

The global Meningococcal Vaccine market size is predicted to grow from US$ 279 million in 2025 to US$ 365 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.

Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.

In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.

LP Information, Inc. (LPI) ' newest research report, the “Meningococcal Vaccine Industry Forecast” looks at past sales and reviews total world Meningococcal Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Meningococcal Vaccine sales for 2025 through 2031. With Meningococcal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningococcal Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Meningococcal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningococcal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meningococcal Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningococcal Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningococcal Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW

Segmentation by Application:
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

Key Questions Addressed in this Report

What is the 10-year outlook for the global Meningococcal Vaccine market?

What factors are driving Meningococcal Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Meningococcal Vaccine market opportunities vary by end market size?

How does Meningococcal Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.